- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Glenmark Acquires and Launches Acetylcysteine Injection | 2 | Contract Pharma | ||
| Mo | Glenmark Pharmaceuticals USA Buys, Launches Acetylcysteine Injection 6 Gm/30 ML Single-Dose Vials | 150 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine... ► Artikel lesen | |
| Mo | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials | 43 | PR Newswire | MAHWAH, N.J., March 3, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection,... ► Artikel lesen | |
| Mo | Glenmark Pharma gains after arm launches Acetylcysteine injection | 3 | capitalmarket.com | ||
| Mo | Glenmark shares in focus after recall of 15 lakh bottles of ADHD drug in US | 4 | Times of India | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| Mo | Stocks in news: M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma | 4 | Times of India | ||
| Do | Glenmark Pharmaceuticals USA Launches Epinephrine Injection USP 10 Mg/10 ML Multiple-Dose Vial | 284 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Limited US, Thursday announced the launch of Epinephrine Injection USP, 10 mg/10 mL Multiple-Dose Vial.The company added that the newly launched... ► Artikel lesen | |
| Do | Glenmark Pharma's US arm launches Epinephrine Injection USP, 10 mg/10 mL | 4 | capitalmarket.com | ||
| 24.02. | Glenmark to pay $7 million to settle lawsuits with three entities in US | 2 | ZEE Business | ||
| 24.02. | Glenmark Pharma gains on settling U.S. antitrust lawsuits for $7 million | 2 | capitalmarket.com | ||
| 19.02. | TCS, Glenmark Pharma among 5 stocks with short buildup | 3 | Times of India | ||
| 19.02. | Stocks to buy in 2025: UltraTech Cements, Glenmark Pharma among top 5 ideas that could give 20-30% returns | 2 | Times of India | ||
| 17.02. | Stocks in news: M&M, Paytm and Glenmark Pharma among 7 stocks that hogged limelight today | 5 | ZEE Business | ||
| 17.02. | No revision, Glenmark Pharma sticking to full-year guidance: VS Mani | 5 | Times of India | ||
| 17.02. | Glenmark Pharma gains on reporting turnaround PAT of Rs 348 crore in Q3 | 3 | capitalmarket.com | ||
| 17.02. | Glenmark Pharmaceuticals gains up to 6% on return to profitability in Q3 | 3 | ZEE Business | ||
| 17.02. | Glenmark Pharma shares in focus as company swings back to profit in Q3 | 2 | Times of India | ||
| 17.02. | Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro | 2 | Times of India | ||
| 16.02. | Oberoi Realty, Glenmark Pharma among 10 midcap stocks that declined up to 19% this week | 2 | Times of India | ||
| 14.02. | Glenmark Pharmaceuticals Launches Latanoprost Ophthalmic Solution In The U.S. | 500 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Ltd. (GLENMARK.NS), Friday announced that it has introduced Latanoprost Ophthalmic Solution, 0.005 percent, a bioequivalent and therapeutically... ► Artikel lesen |
Seite:
1 2 3 4 Weiter >>
66 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,381 | -3,17 % | Leichte Zugewinne bei der Sinopharm Group-Aktie (2,569 €) | An der Börse notiert das Wertpapier der Sinopharm Group aktuell fester. Die Aktie kostete zuletzt 2,57 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 06.01.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
| CSPC PHARMA | 0,589 | -0,47 % | Die Aktie der CSPC Pharmaceutical Group läuft schlechter: Große Kursverluste! (0,582 €) | Zu den großen Verlierern am Aktienmarkt zählt heute die CSPC Pharmaceutical Group-Aktie . Der Titel verbilligt sich am Freitag deutlich. Mit einem Verlust von 5,52 Prozent gehört heute der Anteilsschein... ► Artikel lesen | |
| WUXI BIOLOGICS | 2,805 | +5,06 % | Aktie von WuXi Biologics unter Druck: Kurs fällt um 11,75 Prozent (2,876 €) | An der Börse fällt aktuell der Anteilsschein von WuXi Biologics negativ auf. Der Kurs der Aktie sackt kräftig ab. Jahreschart der WuXi Biologics Inc-Aktie, Stand 24.02.2025 Zu den großen Verlierern... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,813 | -1,09 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY | ||
| DR REDDYS | 12,200 | +0,83 % | Dr Reddy's Lab gets EIR from USFDA for Hyderabad facility | ||
| GEDEON RICHTER | 27,480 | +1,55 % | Richter Earnings Jump on Higher Revenue, Improved Margins | ||
| ASPEN PHARMACARE | 8,600 | +3,61 % | ASPEN PHARMACARE HOLDINGS LIMITED - Unaudited Interim Group Financial Results For The Six Months Ended 31 December 2024 | ||
| SHANGHAI PHARMACEUTICALS | 1,400 | -2,78 % | Dividendenbekanntmachungen (17.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMPHENOL CORPORATION US0320951017 0,165 USD 0,1482 EUR ATOUR LIFESTYLE HOLDINGS LTD ADR US04965M1062 0,45 USD 0,4042 EUR BASE RESOURCES... ► Artikel lesen | |
| LUYE PHARMA | 0,280 | -1,41 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,070 | -7,33 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,635 | 0,00 % | Dividendenbekanntmachungen (10.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AIA GROUP LTD ADR US0013172053 0,2009 USD 0,182 EUR ARGOSY PROPERTY LIMITED NZARGE0010S7 0,008 NZD 0,0044 EUR AUBURN NATIONAL BANCORPORATION... ► Artikel lesen | |
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,030 | -2,83 % | SHINEWAY PHARM (02877): TURNOVER FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024 | ||
| HANSOH PHARMACEUTICAL | 2,220 | -0,89 % | Silence slows phase 3 plans for cardio drug, as Hansoh opts out of $1.3B biobucks collab | ||
| KALBE FARMA | 0,053 | 0,00 % | Kalbe Farma withdraws 61.7 million treasury shares: Kalbe Farma to withdraw treasury shares, capital ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT MONTHLY UPDATE IN RELATION TO THE PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LIMITED kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LIMITED finden Sie auf Wallstreet Online.
